MHLW Orders Label Revisions for Mitsubishi Tanabe’s Zione; “Anaphylaxis” to Be Added to Adverse Reactions

The Ministry of Health, Labor and Welfare (MHLW) ordered on November 27 a revision to package inserts of Mitsubishi Tanabe Pharma’s hemorrhoid treatment Zione Injection (aluminum potassium sulfate + tannic acid) to add “anaphylaxis” to the clinically significant adverse drug...read more